XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Shares outstanding, beginning balance (in shares) at Mar. 31, 2022   175,290,143    
Beginning balance at Mar. 31, 2022 $ 217,061 $ 1 $ 465,313 $ (248,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (15,408)     (15,408)
Issuance for stock options exercised (in shares)   702,176    
Issuance for stock options exercised 154   154  
Issuance for common stock vested (in shares)   106,399    
Issuance for common stock vested 0      
Stock-based compensation 4,343   4,343  
Cumulative translation adjustment 5     5
Shares outstanding, ending balance (in shares) at Jun. 30, 2022   176,098,718    
Ending balance at Jun. 30, 2022 $ 206,155 $ 1 469,810 (263,656)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2023 177,647,754 177,647,754    
Beginning balance at Mar. 31, 2023 $ 170,537 $ 1 480,370 (309,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (11,663)     (11,663)
Issuance for stock options exercised (in shares)   85,956    
Issuance for stock options exercised 81   81  
Issuance for common stock vested (in shares)   1,160,744    
Issuance for common stock vested 0      
Issuance of common stock in connection with the employee stock purchase plan (in shares)   246,733    
Issuance of common stock in connection with the employee stock purchase plan 286   286  
Common stock withheld for tax upon release (in shares)   (380,587)    
Common stock withheld for tax upon release (530)   (530)  
Stock-based compensation 3,225   3,225  
Cumulative translation adjustment $ 2     2
Shares outstanding, ending balance (in shares) at Jun. 30, 2023 178,760,600 178,760,600    
Ending balance at Jun. 30, 2023 $ 161,938 $ 1 $ 483,432 $ (321,495)